An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020845
Company: MALLINCKRODT HOSP

Products on NDA 020845

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
INOMAX	NITRIC OXIDE	100PPM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	GAS;INHALATION	Discontinued	None	Yes	No
INOMAX	NITRIC OXIDE	800PPM	GAS;INHALATION	Prescription	AA	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 020845

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/23/1999	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20845lbl.htm https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20845ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20845_INOmax.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/17/2023	SUPPL-21	Manufacturing (CMC)-New Strength	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020845Orig1s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/020845Orig1s021ltr.pdf
02/13/2019	SUPPL-20	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020845s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020845Orig1s020ltr.pdf
04/05/2016	SUPPL-18	Labeling-Container/Carton Labels	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020845Orig1s018ltr.pdf
10/09/2015	SUPPL-17	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020845s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020845Orig1s016,s017ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/020845Orig1s017.pdf
10/09/2015	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020845s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020845Orig1s016,s017ltr.pdf
02/28/2014	SUPPL-15	Manufacturing (CMC)		Label is not available on this site.
03/04/2013	SUPPL-14	Labeling-Package Insert	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020845s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020845Orig1s014ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/020845Orig1s014.pdf
12/21/2010	SUPPL-11	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020845s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020845s011ltr.pdf
08/26/2009	SUPPL-9	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020845s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020845s009ltr.pdf
12/04/2007	SUPPL-4	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020845s004ltr.pdf
06/15/2004	SUPPL-2	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20845slr002ltr.pdf
05/21/2001	SUPPL-1	Labeling		Label is not available on this site.

Labels for NDA 020845

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/17/2023	SUPPL-21	Manufacturing (CMC)-New Strength	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020845Orig1s021lbl.pdf
02/13/2019	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020845s020lbl.pdf
10/09/2015	SUPPL-17	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020845s016s017lbl.pdf
10/09/2015	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020845s016s017lbl.pdf
03/04/2013	SUPPL-14	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020845s014lbl.pdf
12/21/2010	SUPPL-11	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020845s011lbl.pdf
08/26/2009	SUPPL-9	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020845s009lbl.pdf
12/23/1999	ORIG-1	Approval			https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20845lbl.htm

Therapeutic Equivalents for NDA 020845

INOMAX

GAS;INHALATION; 800PPM
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
INOMAX	NITRIC OXIDE	800PPM	GAS;INHALATION	Prescription	Yes	AA	020845	MALLINCKRODT HOSP
NOXIVENT	NITRIC OXIDE	800PPM	GAS;INHALATION	Prescription	No	AA	207141	LINDE GAS EQUIP

Top